Schedule 13D ownership disclosure
Strongbridge Biopharma plc
Security class unavailable · CUSIP: G85347105
Event date: 2021-10-05
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 0.0000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000919574-22-000045
- Form type
- SC 13D
- Filer
- CAXTON CORP
- CIK
- CIK 1388551
- Filed
- Jan 05, 2022
- Reporting period
- Oct 05, 2021
- Description
- Schedule 13D beneficial ownership